Fluticasone Propionate Aerosol, Metered
Product Images NDC 68462-937

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 68462-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Actuatorlabel (Actuatorlabel)

Actuatorlabel (Actuatorlabel)
Label for Fluticasone Propionate Inhalation Aerosol USP 44 mcg, a metered-dose aerosol inhalation product. The label indicates 120 metered actuations per canister, with instructions to use only with specified 120-actuation canisters and to shake well before use. The labeler is Glenmark Pharmaceuticals Inc., USA.*
FDA Label Image

Canister (Canister)

Canister (Canister)
Fluticasone Propionate Inhalation Aerosol USP 44 mcg metered aerosol label shows 120 metered actuations for oral inhalation only. The label includes NDC 68462-937-20 and is distributed by Glenmark Pharmaceuticals Inc., USA. Net weight is 10.6 g. Storage and usage instructions are noted, along with contact information and barcodes.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Fluticasone Propionate Inhalation Aerosol USP 44 mcg metered aerosol inhaler carton including storage, usage warnings, and dosage information. The label indicates 120 metered actuations, Rx only, net weight 10.6 g, and is distributed by Glenmark Pharmaceuticals Inc., USA with NDC 68462-937-20.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Line graph comparing percentage change from baseline in FEV1 over 12 weeks plus endpoint for placebo and Fluticasone Propionate Inhalation Aerosol 88 mcg twice daily. The x-axis shows weeks, and the y-axis shows percentage change. The Fluticasone Propionate group shows a greater increase over time than placebo.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph depicting the percentage change from baseline in FEV1 (Forced Expiratory Volume in 1 second) over a period of 12 weeks plus an endpoint, comparing placebo and three doses of Fluticasone Propionate Inhalation Aerosol (88 mcg, 220 mcg, and 440 mcg twice daily). The graph shows increasing improvement in FEV1 with higher doses of the aerosol compared to placebo, which shows a decline at the endpoint.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
Bar chart comparing the percentage of subjects who experienced a 100% reduction in dose and those with an increase in dose between placebo and two dosing levels of Fluticasone Propionate Inhalation Aerosol (440 mcg and 880 mcg twice daily). The chart shows higher reduction percentages for both fluticasone groups compared to placebo, and a higher increase in dose percentage for placebo than the treatment groups.*
FDA Label Image

Figurea (Figurea)

Figurea (Figurea)
Illustration of a fluticasone propionate inhaler showing labeled parts: metal canister, white plastic actuator, white mouthpiece, counter, and maroon cap. The diagram highlights the design and components of the aerosol metered inhaler device.*
FDA Label Image

Figureb (Figureb)

Figureb (Figureb)
An instructional illustration showing a hand holding a fluticasone propionate inhaler with the other hand removing the cap from the mouthpiece. The image demonstrates proper removal of the cap before use.*
FDA Label Image

Figurec (Figurec)

Figurec (Figurec)
An instructional illustration showing a person using a metered-dose inhaler by pressing down on the canister to spray medication. The illustration depicts the inhaler spraying with a cap placed on a surface below.*
FDA Label Image

Figured.jpg (Figured)

Figured.jpg (Figured)
An instructional line drawing showing a hand holding a metered dose inhaler spray, demonstrating the familiar grip and finger placement for use. The inhaler detail includes a zoomed-in section highlighting the number "120" on the device, likely indicating remaining doses or actuator count.*
FDA Label Image

Figuree (Figuree)

Figuree (Figuree)
Illustration depicting proper use of the FLUTICASONE PROPIONATE 44 mcg metered-dose inhaler by Glenmark Pharmaceuticals, showing a hand holding the inhaler in the mouthpiece-down position. The diagram labels the white mouthpiece and the removed cap, emphasizing correct orientation for respiratory inhalation.*
FDA Label Image

Figuref (Figuref)

Figuref (Figuref)
An instructional illustration showing a side profile of a person breathing out with the text 'Breathe out as much air as you can' and an arrow indicating the direction of air flow out of the mouth.*
FDA Label Image

Figureg (Figureg)

Figureg (Figureg)
An instructional illustration showing a person using a metered-dose inhaler. The person holds the inhaler near their mouth, with text and an arrow indicating to push down on the inhaler while breathing in. The diagram demonstrates the proper technique for inhalation of the aerosol medication.*
FDA Label Image

Figureh (Figureh)

Figureh (Figureh)
An instructional illustration showing a person rinsing their mouth by spitting water into a sink, with a glass of water and a faucet visible in the background. The image likely relates to aftercare following inhalation therapy.*
FDA Label Image

Figurei (Figurei)

Figurei (Figurei)
An instructional illustration showing proper use of a metered aerosol inhaler. The top image labeled 'Not blocked' shows the inhaler releasing a visible mist, while the bottom image labeled 'Blocked' depicts the inhaler with reduced spray, indicating an obstructed nozzle.*
FDA Label Image

Figurej (Figurej)

Figurej (Figurej)
An instructional diagram showing a hand holding a small cotton swab or applicator near a spray nozzle or opening. The swab is being rotated in a circular motion, indicating cleaning or preparation of the nozzle area on a device resembling an inhaler spray top.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Logo3 (Logo3)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of fluticasone propionate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.